Amarin Corporation plc

0.7500-0.0320-4.09%Vol 1.63M1Y Perf -34.29%
Dec 1st, 2023 16:00 DELAYED
BID0.7430 ASK0.7600
Open0.7603 Previous Close0.7820
Pre-Market- After-Market0.75
 - -  - -%
Target Price
3.33 
Analyst Rating
Hold 3.33
Potential %
344.00 
Finscreener Ranking
★★★★+     55.23
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★★+     54.07
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★★+     55.90
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
6.27 
Earnings Rating
Strong Buy
Market Cap306.22M 
Earnings Date
1st Nov 2023
Alpha-0.04 Standard Deviation0.24
Beta2.11 

Today's Price Range

0.74000.7799

52W Range

0.65102.23

5 Year PE Ratio Range

-51.90-10.90

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-0.10%
1 Month
12.00%
3 Months
-26.23%
6 Months
-35.37%
1 Year
-34.29%
3 Years
-84.07%
5 Years
-95.66%
10 Years
-57.03%

TickerPriceChg.Chg.%
AMRN0.7500-0.0320-4.09
AAPL191.241.29000.68
GOOG133.32-0.6000-0.45
MSFT374.51-4.4000-1.16
XOM102.990.25000.24
WFC45.020.43000.96
JNJ158.383.72002.41
FB196.640.99000.51
GE122.500.70000.57
JPM156.840.76000.49
Financial StrengthValueIndustryS&P 500US Markets
1.50
2.40
0.02
0.02
276.40
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
69.10
-18.80
-18.10
-15.50
-38.24
RevenueValueIndustryS&P 500US Markets
278.95M
0.69
37.61
43.15
Earnings HistoryEstimateReportedSurprise %
Q03 2023-0.05-0.050.00
Q02 2023-0.04-0.040.00
Q01 2023-0.03-0.04-33.33
Q04 2022-0.010.00100.00
Q03 2022-0.06-0.0183.33
Q02 2022-0.07-0.18-157.14
Q01 2022-0.02-0.08-300.00
Q04 2021-0.010.04500.00
Earnings Per EndEstimateRevision %Trend
12/2023 QR-0.0625.00Positive
12/2023 FY-0.199.52Positive
3/2024 QR-0.0614.29Positive
12/2024 FY-0.195.00Positive
Next Report Date-
Estimated EPS Next Report-0.05
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume1.63M
Shares Outstanding408.29K
Shares Float372.32M
Trades Count3.10K
Dollar Volume1.24M
Avg. Volume1.26M
Avg. Weekly Volume950.31K
Avg. Monthly Volume1.30M
Avg. Quarterly Volume1.54M

Amarin Corporation plc (NASDAQ: AMRN) stock closed at 0.782 per share at the end of the most recent trading day (a 4.27% change compared to the prior day closing price) with a volume of 1.22M shares and market capitalization of 306.22M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 1000 people. Amarin Corporation plc CEO is John F. Thero.

The one-year performance of Amarin Corporation plc stock is -34.29%, while year-to-date (YTD) performance is -35.37%. AMRN stock has a five-year performance of -95.66%. Its 52-week range is between 0.651 and 2.23, which gives AMRN stock a 52-week price range ratio of 6.27%

Amarin Corporation plc currently has a PE ratio of -6.30, a price-to-book (PB) ratio of 0.99, a price-to-sale (PS) ratio of 2.14, a price to cashflow ratio of 329.80, a PEG ratio of -, a ROA of -10.30%, a ROC of -14.87% and a ROE of -16.25%. The company’s profit margin is -38.24%, its EBITDA margin is -18.10%, and its revenue ttm is $278.95 Million , which makes it $0.69 revenue per share.

Of the last four earnings reports from Amarin Corporation plc, there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.05 for the next earnings report. Amarin Corporation plc’s next earnings report date is -.

The consensus rating of Wall Street analysts for Amarin Corporation plc is Hold (3.33), with a target price of $3.33, which is +344.00% compared to the current price. The earnings rating for Amarin Corporation plc stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Amarin Corporation plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Amarin Corporation plc has a Neutral technical analysis rating based on Technical Indicators (ADX : 21.02, ATR14 : 0.05, CCI20 : 47.18, Chaikin Money Flow : 0.15, MACD : 0.00, Money Flow Index : 42.00, ROC : 7.95, RSI : 52.34, STOCH (14,3) : 67.65, STOCH RSI : 1.00, UO : 54.12, Williams %R : -32.35), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Amarin Corporation plc in the last 12-months were: Aaron D. Berg (Option Excercise at a value of $0), Karim Mikhail (Option Excercise at a value of $0), Mikhail Karim (Sold 0 shares of value $0 ), Olsen Per Wold (Sold 0 shares of value $0 ), Per Wold-Olsen (Option Excercise at a value of $0), Steven B. Ketchum (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (16.67 %)
2 (40.00 %)
2 (40.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (50.00 %)
2 (40.00 %)
2 (40.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
2 (33.33 %)
1 (20.00 %)
1 (20.00 %)
Summary RatingHold
3.33
Hold
2.60
Hold
2.60

Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa.

CEO: John F. Thero

Telephone: +353 16699020

Address: 77 Sir John Rogerson's Quay, Dublin D02 VK60, , IE

Number of employees: 1 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

61%39%

Bearish Bullish

56%44%

 

News

Stocktwits